Treatment of clinically severe bovine mastitis – a scoping review
Open Access
- 19 January 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 11, 1286461
Abstract
Mastitis is a major health problem for bovines and can be categorized as non-severe or severe, based on clinical symptoms. A severe case of clinical mastitis is usually defined by the cow being affected systemically. It is important to consider how to handle severe cases because these cases can be fatal and cause high production losses. However, there are generally few detailed treatment guidelines. By conducting a scoping review on the topic, we aimed to synthesize the information that is available on treatment and outcomes, as reported from clinical trials and observational studies. This was facilitated by following the PRISMA-guidelines with a stepwise systematic screening of scientific literature on the subject, retrieved via Pubmed and Web of Science, using pre-defined selection criteria. The results yielded a total of 14 reports of treatment and outcomes in cases of naturally occurring severe clinical mastitis. Cross-trial comparison was difficult due to the different exclusion criteria and outcome definitions. Many studies focused on cases caused by gram-negative bacteria treated with intensive antibiotic protocols, often containing antibiotics that are categorized as critical for human health. Few focused on severe cases caused by gram-positive bacteria or on the relative use of non-antibiotic treatment. In general, only a small number of statistically significant differences were found in trials comparing different treatment protocols, with no obvious trends across trials. Our findings emphasize the need for more research into the treatment efficacy of antibiotic and non-antibiotic options for clinically severe mastitis. Furthermore, consideration of how trial conditions relate to the practical circumstances in a field setting could improve the applicability of reported results. This could help to provide practitioners with the information needed to make evidence-based treatment decisions in cases of clinically severe mastitis.Keywords
This publication has 50 references indexed in Scilit:
- Evaluation of increased milking frequency as an additional treatment for cows with clinical mastitisJournal of Dairy Research, 2009
- Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acuteEscherichia colibovine mastitisJournal of Dairy Research, 2008
- Comparison of disease severity scoring systems for dairy cattle with acute coliform mastitisJournal of the American Veterinary Medical Association, 2006
- The efficacy of bovine lactoferrin in the treatment of cows with experimentally inducedEscherichia colimastitisJournal of Veterinary Pharmacology and Therapeutics, 2004
- Evaluation of frequent milkout for treatment of cows with experimentally induced Escherichia coli mastitisJournal of the American Veterinary Medical Association, 2003
- Tumor necrosis factor-α and nitrite/nitrate responses during acute mastitis induced by Escherichia coli infection and endotoxin in dairy cowsDomestic Animal Endocrinology, 2000
- Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: effect on clinical signs and chemiluminescence of circulating neutrophilsJournal of Dairy Research, 2000
- Comparison of fluid and flunixin meglumine therapy in combination and individually in the treatment of toxic mastitisVeterinary Record, 1997
- Naturally Occurring Acute Coliform Mastitis in Holstein CattleJournal of Veterinary Internal Medicine, 1996
- Clinical trial of three therapeutic regimens for bovine mastitisVeterinary Record, 1989